Oncologic complication
(UMLS:C2242489)
- UMLS ID:
- C2242489
- MeSH ID:
- N/A
Synonym(s)
1.
Oncologic complication
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Everolimus | FAERS: 31 | US FAERS | |
| 2 | Imatinib Mesylate | FAERS: 28 | US FAERS | |
| 3 | MDV 3100 | FAERS: 15 | US FAERS | |
| 4 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 7 | US FAERS | |
| 5 | Octreotide | FAERS: 6 | US FAERS | |
| 6 | Sorafenib | FAERS: 6 | US FAERS | |
| 7 | Teriparatide | FAERS: 6 | US FAERS | |
| 8 | Deferasirox | FAERS: 5 | US FAERS | |
| 9 | Capecitabine | FAERS: 4 | US FAERS | |
| 10 | Fentanyl | FAERS: 4 | US FAERS | |
| 11 | Sunitinib | FAERS: 4 | US FAERS | |
| 12 | ponatinib | FAERS: 4 | US FAERS | |
| 13 | Abiraterone Acetate | FAERS: 3 | US FAERS | |
| 14 | Imatinib Mesylate | FAERS: 3 | US FAERS | |
| 15 | Letrozole | FAERS: 3 | OFFSIDES US FAERS | |
| 16 | Valsartan | FAERS: 3 | US FAERS | |
| 17 | Goserelin | FAERS: 2 | US FAERS | |
| 18 | Lapatinib | FAERS: 2 | US FAERS | |
| 19 | Lenalidomide | FAERS: 2 | US FAERS | |
| 20 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 21 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 22 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 23 | Somatuline Autogel | FAERS: 2 | US FAERS | |
| 24 | Sunitinib | FAERS: 2 | OFFSIDES US FAERS | |
| 25 | Vemurafenib | FAERS: 2 | US FAERS | |
| 26 | dabrafenib | FAERS: 2 | US FAERS | |
| 27 | isavuconazole | FAERS: 2 | US FAERS | |
| 28 | olaparib | FAERS: 2 | US FAERS | |
| 29 | pomalidomide | FAERS: 2 | US FAERS | |
| 30 | regorafenib | FAERS: 2 | US FAERS | |
| 31 | telotristat ethyl | FAERS: 2 | US FAERS | |
| 32 | trandolapril | FAERS: 2 | OFFSIDES US FAERS | |
| 33 | venetoclax | FAERS: 2 | US FAERS | |
| 34 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 35 | Acitretin | FAERS: 1 | US FAERS | |
| 36 | Afatinib | FAERS: 1 | US FAERS | |
| 37 | Albuterol | FAERS: 1 | US FAERS | |
| 38 | Aprepitant | FAERS: 1 | US FAERS | |
| 39 | Bendamustine Hydrochloride | FAERS: 1 | US FAERS | |
| 40 | Bortezomib | FAERS: 1 | US FAERS | |
| 41 | Cabozantinib S-malate | FAERS: 1 | US FAERS | |
| 42 | Carbidopa, levodopa, and entacapone | FAERS: 1 | US FAERS | |
| 43 | Carboplatin | FAERS: 1 | US FAERS | |
| 44 | Clozapine | FAERS: 1 | US FAERS | |
| 45 | Cyclosporine | FAERS: 1 | US FAERS | |
| 46 | Dabigatran | FAERS: 1 | US FAERS | |
| 47 | Dasatinib | FAERS: 1 | US FAERS | |
| 48 | Epirubicin | FAERS: 1 | US FAERS | |
| 49 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 50 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 51 | Etoposide | FAERS: 1 | US FAERS | |
| 52 | Fluticasone-Salmeterol Drug Combination | FAERS: 1 | US FAERS | |
| 53 | Fluticasone | FAERS: 1 | US FAERS | |
| 54 | Fosamax plus D | FAERS: 1 | US FAERS | |
| 55 | HhAntag691 | FAERS: 1 | US FAERS | |
| 56 | Insulin Glargine | FAERS: 1 | US FAERS | |
| 57 | Paliperidone Palmitate | FAERS: 1 | US FAERS | |
| 58 | Prednisolone | FAERS: 1 | US FAERS | |
| 59 | Raltegravir Potassium | FAERS: 1 | US FAERS | |
| 60 | Temozolomide | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 61 | Tenofovir | FAERS: 1 | US FAERS | |
| 62 | Thyroxine | FAERS: 1 | US FAERS | |
| 63 | Valganciclovir | FAERS: 1 | US FAERS | |
| 64 | Warfarin | FAERS: 1 | US FAERS | |
| 65 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 66 | ambrisentan | FAERS: 1 | US FAERS | |
| 67 | dolasetron | FAERS: 1 | US FAERS | |
| 68 | glycerol phenylbutyrate | FAERS: 1 | US FAERS | |
| 69 | osimertinib | FAERS: 1 | US FAERS | |
| 70 | palbociclib | FAERS: 1 | US FAERS | |
| 71 | pazopanib | FAERS: 1 | US FAERS | |
| 72 | tegaserod | FAERS: 1 | US FAERS | |
| 73 | temsirolimus | FAERS: 1 | US FAERS | |
| 74 | Codeine | OFFSIDES | ||
| 75 | Dactinomycin | OFFSIDES | ||
| 76 | Octreotide | OFFSIDES | ||
| 77 | Pemetrexed | OFFSIDES | ||
| 78 | Rivastigmine | OFFSIDES | ||
| 79 | darifenacin | OFFSIDES | ||
| 80 | dolasetron | OFFSIDES | ||
| 81 | lanreotide | Canada Vigilance: 2 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.